Dexcom (DXCM) Current Deferred Revenue (2010 - 2025)
Dexcom (DXCM) posted quarterly Current Deferred Revenue of $2.9 million for Q3 2025, down 79.14% year-over-year from $13.9 million in Q3 2024, and down 52.46% quarter-over-quarter from $6.1 million in Q2 2025.
Dexcom (DXCM) Current Deferred Revenue (2010 - 2025) Analysis & Trends
Dexcom (DXCM) has reported Current Deferred Revenue for 16 consecutive years, with $2.9 million the latest figure, recorded in Q3 2025.
- In Q3 2025, Current Deferred Revenue fell 79.14% year-over-year to $2.9 million; the TTM figure through Sep 2025 stood at $2.9 million (down 79.14% YoY), while the FY2024 annual figure was $8.0 million, down 56.52% from the prior year.
- Current Deferred Revenue retreated to $2.9 million in Q3 2025 per DXCM's latest filing, from $6.1 million in the prior quarter.
- Across five years, Current Deferred Revenue topped out at $18.4 million in Q4 2023 and bottomed at $1.8 million in Q2 2021.
- Historically, Current Deferred Revenue has averaged $7.5 million across 5 years, with a median of $7.8 million in 2025.
- Annual changes were most pronounced in 2022 — Current Deferred Revenue soared 380.95% — and 2025, when it sank 79.14%.
- Dexcom's Current Deferred Revenue stood at $2.1 million in 2021, then jumped by 380.95% to $10.1 million in 2022, then jumped by 82.18% to $18.4 million in 2023, then plunged by 56.52% to $8.0 million in 2024, then tumbled by 63.75% to $2.9 million in 2025.
- Business Quant data shows DXCM's Current Deferred Revenue at $2.9 million in Q3 2025, $6.1 million in Q2 2025, and $7.8 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.51 Bn | 194.91 Bn | 7.27 Bn |
| 2 | Stryker | 129.96 Bn | 126.48 Bn | 4.50 Bn |
| 3 | Medtronic | 120.18 Bn | 110.96 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.28 Bn | 73.74 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.75 Bn | 48.50 Bn | 1.35 Bn |
| 6 | Dexcom | 34.67 Bn | 32.73 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.23 Bn | 32.12 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn |
| 9 | Steris | 23.30 Bn | 22.82 Bn | 684.20 Mn |
| 10 | Zimmer Biomet Holdings | 19.38 Bn | 18.97 Bn | 1.54 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 2.90 Mn |
| Jun 30, 2025 | 6.10 Mn |
| Mar 31, 2025 | 7.80 Mn |
| Dec 31, 2024 | 8.00 Mn |
| Sep 30, 2024 | 13.90 Mn |
| Jun 30, 2024 | 14.70 Mn |
| Mar 31, 2024 | 16.40 Mn |
| Dec 31, 2023 | 18.40 Mn |
| Sep 30, 2023 | 9.00 Mn |
| Jun 30, 2023 | 9.00 Mn |
| Mar 31, 2023 | 9.60 Mn |
| Dec 31, 2022 | 10.10 Mn |
| Sep 30, 2022 | 2.70 Mn |
| Jun 30, 2022 | 2.70 Mn |
| Mar 31, 2022 | 2.70 Mn |
| Dec 31, 2021 | 2.10 Mn |
| Sep 30, 2021 | 2.30 Mn |
| Jun 30, 2021 | 1.80 Mn |
| Mar 31, 2021 | 1.90 Mn |
| Dec 31, 2020 | 2.20 Mn |